STERIS plc (NYSE:STE) Weekly Ratings as of May 17, 2018

May 17, 2018 - By Mary Kidd

STERIS plc (NYSE:STE) Corporate Logo
During Q4 2017 the big money sentiment decreased to 0.17. That’s change of 0.33, from 2017Q3’s 0.5. 4 investors sold all, 2 reduced holdings as STERIS plc ratio is negative. 0 grew holdings while 1 funds amassed holdings. Funds hold 19,649 shares thus 85.67% less from 2017Q3’s 137,131 shares.
Moreover, Hanson And Doremus Inv Mgmt has 0.04% invested in STERIS plc (NYSE:STE) for 1,500 shs. Fruth Inv Management invested in 14,076 shs or 0.52% of the stock. Prudential Public Ltd Co accumulated 3,800 shs. Shine Invest Advisory accumulated 123 shs. Alphamark Advsr Ltd Limited Liability Company invested in 150 shs.

STERIS plc (NYSE:STE) Ratings Coverage

A total of 3 analysts rate STERIS (NYSE:STE) as follows: 2 “Buy”, 1 “Hold” and 0 “Sell”. Тherefore 67% are bullish. (NYSE:STE) has 3 ratings reports on May 17, 2018 according to StockzIntelligence. On Thursday, February 8 the stock has “Buy” rating by KeyBanc Capital Markets. On Thursday, February 8 the stock has “Buy” rating by Northcoast. On Wednesday, January 3 the company was downgraded by Raymond James. Listed here are STERIS plc (NYSE:STE) PTs and latest ratings.

08/02/2018 Broker: KeyBanc Capital Markets Rating: Buy New Target: $103.0 Maintain
08/02/2018 Broker: Northcoast Rating: Buy New Target: $102.0 Maintain
03/01/2018 Broker: Raymond James Old Rating: Outperform New Rating: Market Perform Old Target: $100 Downgrade

STE touched $103.28 during the last trading session after $0.36 change.Currently STERIS plc is uptrending after 32.31% change in last May 17, 2017. STE has 302,150 shares volume. STE outperformed by 20.76% the S&P 500.

STERIS plc develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and surgical and gastrointestinal support services and products for healthcare, pharmaceutical, scientific, research, industrial, and governmental clients worldwide.The company has $8.76 billion market cap. The companyÂ’s Healthcare Products segment offers steam, vaporized hydrogen peroxide, and ethylene oxide sterilizers, as well as liquid chemical sterilant processing systems; automated washer/disinfector systems; general and specialty surgical tables, surgical and examination lights, equipment management systems, operating room storage cabinets, warming cabinets, scrub sinks, and other accessories; and gastrointestinal devices and accessories.The P/E ratio is 36.38. It also provides OR integration, OR and sterile processing department, workflow, patient tracking, and instrument management solutions; and cleaning chemistries and sterility assurance products.

There’s a significant STERIS plc (NYSE:STE) news published by Seekingalpha.com. It’s an item titled: “STERIS Plc (STE) Q4 2018 Results – Earnings Call Transcript” on May 09, 2018.

STERIS plc (NYSE:STE) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.